Mitochondria are the main sources of energy in the cell. They are unique mammalian organelles because they contain their own DNA (mtDNA), whose genes encode components of the respiratory chain/oxidative phosphorylation system. They are essential for the normal functioning of all cells in the body, and are absolutely critical for the function of those tissues that are highly dependent on aerobic metabolism, including heart, skeletal muscle, and brain. Since 1988, single large-scale mtDNA rearrangements, more than 100 mtDNA point mutations, as well as mendelian-inherited multiple mtDNA deletions have been associated with human diseases. Mitochondrial neuro-gastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder associated with multiple deletions and depletion of mtDNA in skeletal muscle. The major clinical features are: ptosis, external ophthalmoparesis, gastrointestinal dysmotility, cachexia, peripheral neuropathy, and leukodystrophy. We mapped the disease to chromosome 22q13.32-qter and subsequently identified loss-of-function mutations in the thymidine phosphorylase (TP) gene as the cause of the disorder. With the support of a NIH grant, we have continued our investigation of MNGIE. Clinicians from around the world have sent us blood samples to test for defects in thymidine phosphorylase. To date, we have identified 51 MNGIE patients. All patients tested have shown very low or no detectable activity of thymidine phosphorylase in huffy coat samples. In addition, we have identified dramatic increases of thymidine levels in plasma from patients. These findings led us to hypothesize that elevated intracellular levels of thymidine cause alterations of mitochondrial nucleotide pools that, in turn, induce point mutations, multiple deletions, and depletion of mtDNA. To test our hypothesis, we propose to study this disorder in vivo using human autopsy samples and in vitro using fibroblasts from patients. In addition, we have produced thymidine phosphorylase knock-out mice as a model for MNGIE. Our proposed studies of the pathogenesis of MNGIE are likely to enhance our understanding of nucleotide metabolism and will likely lead to more rational therapies for this uncommon, but devastating illness.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS011766-28
Application #
7557044
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
28
Fiscal Year
2004
Total Cost
$227,867
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Akman, H Orhan; Aykit, Yavuz; Amuk, Ozge Ceren et al. (2016) Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1. Neuromuscul Disord 26:16-20
Quinzii, Catarina M; Hirano, Michio; DiMauro, Salvatore (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:81-2
Cámara, Yolanda; González-Vioque, Emiliano; Scarpelli, Mauro et al. (2014) Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. Hum Mol Genet 23:2459-67
Li, Wei; Gigante, Alba; Perez-Perez, Maria-Jesus et al. (2014) Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. Circ Res 115:997-1006
Vara, Dina S; Campanella, Michelangelo; Canobbio, Ilaria et al. (2013) Autocrine amplification of integrin ?IIb?3 activation and platelet adhesive responses by deoxyribose-1-phosphate. Thromb Haemost 109:1108-19
Pfeffer, Gerald; Horvath, Rita; Klopstock, Thomas et al. (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9:474-81
Martí, Ramon; López, Luis C; Hirano, Michio (2012) Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity. Methods Mol Biol 837:121-33
Martí, Ramon; Dorado, Beatriz; Hirano, Michio (2012) Measurement of mitochondrial dNTP pools. Methods Mol Biol 837:135-48
Hirano, Michio; Quinzii, Catarina M; Mitsumoto, Hiroshi et al. (2011) Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12:223-7
Douglas, Ganka V; Wiszniewska, Joanna; Lipson, Mark H et al. (2011) Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis. J Hum Genet 56:834-9

Showing the most recent 10 out of 81 publications